The Traderszone Network

Published in TZ Latest News 20 October, 2016 by The TZ Newswire Staff

Alkermes depression drug meets main goal; shares surge

Alkermes said its lead depression drug met the main goal of a late-stage trial, sending its shares up 48 percent in extended trading.